Results 111 to 120 of about 25,438 (199)

A new, glycoengineered form of anti-CD20 monoclonal antibody, in treatment of multiple sclerosis. [PDF]

Ther Adv Neurol Disord
Selmaj K, Gold R, Selmaj I, Mycko MP.
europepmc   +1 more source

A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer. [PDF]

Jpn J Clin Oncol
Nagatani Y, Kiyota N, Yamazaki T, Asada Y, Higashino M, Satake H, Boku S, Nishimura A, Uemura H, Ota I, Yane K, Tanaka K, Onoe T, Hirayama Y, Tsujikawa T, Fujiwara H, Shimoda H, Nibu KI, Imamura Y, Kimbara S, Koyama T, Funakoshi Y, Minami H.   +22 more
europepmc   +1 more source

Selective fluorination of Fc glycans enhances antibody-mediated effector functions. [PDF]

Proc Natl Acad Sci U S A
Wang X, Gomozkova M, Li S, Banerjee B, Zong G, Missiakas D, Wang LX.   +6 more
europepmc   +1 more source

Targeting NKG2DLs with an ADCC enhanced fusion protein for induction of NK cell reactivity against ovarian cancer. [PDF]

J Ovarian Res
Hagelstein I, Wang K, Hölz A, Blessing J, Lutz MS.   +4 more
europepmc   +1 more source

Targeting ST3GAL1 to downregulate ligands for the glycoimmune checkpoint Siglec-7 and reverse immune escape in hepatocellular carcinoma. [PDF]

Cancer Immunol Immunother
Fan TC, Hung TH, Yeh CT, Lin PT, Chang NC, Lo TC, Wu TJ, Yu J, Yu AL.   +8 more
europepmc   +1 more source

[Corrigendum] Role of hypoxia‑inducible factor‑1α and CD146 in epidermal growth factor receptor‑mediated angiogenesis in salivary gland adenoid cystic carcinoma [PDF]

Mol Med Rep
Wang WM, Zhao ZL, Zhang WF, Zhao YF, Zhang L, Sun ZJ.   +5 more
europepmc   +1 more source

Prognostic impact of HLA class I immunohistochemistry staining intensity with regard to the risk of recurrence of adenoid cystic carcinoma. [PDF]

Mol Clin Oncol
Zupancic M, Birgersson M, Friesland S, Dalianis T, Näsman A.   +4 more
europepmc   +1 more source

ADCC (No.68～72)

Japanese Journal of Clinical Immunology, 1978
openaire   +2 more sources

Anisotropic gold nanochains with dual-ligand interfaces for theranostic immune activation. [PDF]

RSC Adv
Yang C, Son YJ, Jin S, Park Y, Jung YM, Kang SG, Yoo HS.   +6 more
europepmc   +1 more source

A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers. [PDF]

ESMO Open
Alfieri S, Rota S, Romanò R, Capone I, Busico A, Conca E, Tamborini E, Cavalieri S, Buriolla S, Sciortino C, Leone AG, Nuzzolese I, Ottini A, Bergamini C, Quattrone P, Vingiani A, Locati LD, Licitra L, Pruneri G, Colombo E, Agnelli L, Perrone F.   +21 more
europepmc   +1 more source